Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$2.60 B

According to Guardant Health 's latest financial reports the company's total assets are NZ$2.60 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$2.82 B11.4%
2022-12-31NZ$2.53 B-21.22%
2021-12-31NZ$3.21 B1.91%
2020-12-31NZ$3.15 B121.37%
2019-12-31NZ$1.42 B63.02%
2018-12-31NZ$0.87 B81.27%
2017-12-31NZ$0.48 B186.95%
2016-12-31NZ$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$2.45 B-5.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.35 B 182.65%๐Ÿ‡บ๐Ÿ‡ธ USA